Skip to main content
FinSpry Logo
FinSpry
PACB logo
PACB
(NASDAQ)
Pacific Biosciences of California, Inc.
$1.31-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Pacific Biosciences of California (PACB) Financial Ratios

Valuation, profitability, liquidity, and efficiency metrics with annual and quarterly data.

Pacific Biosciences of California Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio-1.03-1.15-8.11-5.84-22.99152.59
P/S Ratio3.533.5013.1014.4434.6444.68
P/B Ratio105.561.063.753.295.72-7.94
Price/Tangible Book104.861.043.553.265.28-72.26
Price/FCF-4.96-2.54-9.80-6.62-38.61-9.64
Price/OCF-5.08-2.61-10.13-7.04-40.67-9.90
Enterprise Value Ratios
EV/Revenue6.175.2714.5615.7333.8951.90
EV/EBITDA-5.76-1.87-9.27-6.80-21.80-9.55
EV/EBIT-1.78-1.71-8.73-6.57-21.02-9.10
EV/FCF-8.66-3.82-10.89-7.21-37.77-11.20
Profitability & Returns
Return on Equity (ROE)-2.13%-0.51%-0.49%-0.46%-0.32%2.23%
Return on Assets (ROA)-0.54%-0.32%-0.18%-0.16%-0.11%-0.56%
Return on Invested Capital (ROIC)-0.86%-0.50%-0.32%-0.33%-0.28%-3.34%
Return on Capital Employed (ROCE)-0.58%-0.33%-0.21%-0.18%-0.18%-0.60%
Leverage & Solvency Ratios
Debt/Equity131.241.311.321.671.20-2.37
Debt/EBITDA-4.10-1.55-2.97-3.19-4.70-2.47
Debt/FCF-6.17-3.17-3.48-3.38-8.14-2.90
Liquidity Ratios
Current Ratio5.157.487.813.2415.3611.76
Quick Ratio4.326.307.033.0014.9010.02
Efficiency Ratios
Asset Turnover0.160.100.110.070.110.10
Inventory Turnover2.021.862.722.093.670.78
Yield & Distribution Ratios
Earnings Yield-0.97%-0.87%-0.12%-0.17%-0.04%0.01%
FCF Yield-0.20%-0.39%-0.10%-0.15%-0.03%-0.10%
Buyback Yield-0.04%-0.14%-0.13%-0.10%-0.17%-0.15%
Total Return-0.04%-0.14%-0.13%-0.10%-0.17%-0.15%

Frequently Asked Questions About Pacific Biosciences of California Financial Ratios

What is the P/E ratio?

The price-to-earnings (P/E) ratio divides the stock price by earnings per share. It shows how much investors pay for each dollar of earnings. A higher P/E may indicate growth expectations, while a lower P/E could suggest undervaluation or slower growth.

What is ROE (Return on Equity)?

ROE measures how effectively a company uses shareholders' equity to generate profit. It's calculated as net income divided by shareholders' equity. Higher ROE indicates more efficient use of equity capital — generally above 15% is considered strong.

What is the current ratio?

The current ratio divides current assets by current liabilities, measuring a company's ability to pay short-term obligations. A ratio above 1.0 means the company has more short-term assets than debts; below 1.0 may signal liquidity risk.

What is debt-to-equity ratio?

Debt-to-equity compares total debt to total shareholders' equity, indicating how much leverage a company uses. A higher ratio means more debt financing. Acceptable levels vary by industry — capital-intensive sectors like utilities typically carry higher ratios.

How do PACB's ratios compare?

Compare Pacific Biosciences of California's valuation ratios (P/E, P/B, EV/EBITDA) and profitability ratios (ROE, ROA, margins) against industry peers and historical trends in the table above. Quarterly data reveals recent changes in financial health.